Skip to contentClarengateINTELLIGENCE
Companies/06557113

Organox Limited

Other research and experimental development on natural sciences and engineering · London

ActiveUnited KingdomIncorporated 2008Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

No electronic account filings

No extracted electronic accounts are available in our records.

Registered details

06557113
Status
Active
Type
Private Limited Company
Incorporated
2008-04-07
Jurisdiction
—
Registered office
125, WOOD STREET, LONDON, EC2V 7AW, UNITED KINGDOM

Classification

1 SIC codes
72190

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

7 SH01-derived rounds
2025-10-22
£4,595,953 raised
£87,775,565 estimated post-money
2025-06-11
£45,357 raised
£11,026,270 estimated post-money
2025-02-24
£21,350,314 raised
£328,053,910 estimated post-money
Venture
2024-05-22
£131,492 raised
£18,907,564 estimated post-money
2023-07-13
£24,257,113 raised
£175,516,142 estimated post-money
2022-06-06
£5,032,478 raised
£87,247,443 estimated post-money
2021-10-15
£9,528,129 raised
£65,074,985 estimated post-money

Research and innovation

4 matched grants
MICA: Optimisation of prolonged normothermic liver machine perfusion and assessment of its feasibility to provide extra-corporeal liver support
MRC · Fellowship · 2022-10-05 – 2025-10-04 · with 3 other participants
£250,506
whole project
University Of OxfordleadOrganOx LtdUniversity Of EdinburghUniversity of Pennsylvania
MICA: Novel approaches in optimising steatotic livers for transplantation
MRC · Fellowship · 2016-09-30 – 2018-09-29 · with 1 other participant
£142,951
whole project
University Of OxfordleadOrganOx Ltd
OxCD3: Oxford Centre for Drug Delivery Devices
EPSRC · Research Grant · 2014-07-22 – 2021-01-22 · with 12 other participants
£6,398,185
whole project
University Of OxfordleadAstrazenecaAstraZenecaCell Therapy LtdKarl Storz GmbH & Co. KGLein Applied Diagnostics LtdNational Institutes of Health (NIH)OrganOx LtdOxford Instruments Group (UK)Pfizer Global R and DPsiOxus TherapeuticsUniversity of TwenteVerasonics, Inc
OrganOx Phase 2 Clinical InvestigationLead
Innovate UK · Collaborative R&D · 2013-10-01 – 2017-03-31
£2,333,921
awarded